A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

BACKGROUND: Lymphovascular invasion (LVI), which includes vascular or lymphatic invasions, is a representative prognostic factor even in patients with resected stage IA non-small cell lung cancer (NSCLC). Because tegafur-uracil is effective on cancers with LVI, we conducted a multi-center single-arm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Tomoshi, Kamohara, Ryotaro, Muraoka, Masashi, Nagayasu, Takeshi, Saeki, Sho, Takenoyama, Mitsuhiro, Suzuki, Makoto, Inada, Kazuo, Tokunaga, Shoji, Hayashi, Tomayoshi, Urabe, Shogo, Koga, Takaomi, Akamine, Shinji, Sugio, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718684/
https://www.ncbi.nlm.nih.gov/pubmed/33276755
http://dx.doi.org/10.1186/s12885-020-07691-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718684/
https://www.ncbi.nlm.nih.gov/pubmed/33276755
http://dx.doi.org/10.1186/s12885-020-07691-7

Ejemplares similares